Skip to main content
. 2016 Feb 21;7(15):19643–19653. doi: 10.18632/oncotarget.7544

Table 2. Cox proportional hazards model for ypN+ patients stratified by age.

HR 95%CI P
Age < 73 years
 Histologic grade
  Well 1.316 0.315–5.503 0.707
  Moderate 1
  Poor/Undifferentiated 2.395 1.336–4.295 0.003
  Unknown 0.565 0.134–2.383 0.437
  Chemotherapy regimens
  5-FU 1
  Oxaliplatin 0.449 0.225–0.899 0.024
Age ≥ 73 years
 ypN category
  ypN1a 1
  ypN1b 0.951 0.444–2.036 0.898
  ypN2a 1.818 0.940–3.516 0.076
  ypN2b 3.217 1.484–6.974 0.003
 Year of diagnosis
  1992–1996 39.044 4.084–373.260 0.001
  1997–2000 2.237 0.944–5.304 0.068
  2001–2004 .920 0.451–1.878 0.820
  2005–2008 1
 HCC risk score
  1st quartile 1
  2nd quartile 0.661 0.303–1.441 0.298
  3rd quartile 0.780 0.347–1.756 0.548
  4th quartile 2.361 1.206–4.624 0.012
 Chemotherapy regimens
  5-FU 1
  Oxaliplatin 1.484 0.701–3.142 0.303

Abbreviation: 5-FU, 5-fluorouracil; CI, Confidential intervals; HCC, Hierarchical Condition Categories.